TT
PFE icon

Tower Trust’s Pfizer PFE Stock Holding History

Tower Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$1.54M Sell
50,487
-4,914
-9% -$147K 0.97% 29
2013
Q4 		$1.61M Buy
55,401
+1,500
+3% +$43.7K 0.97% 31
2013
Q3 		$1.47M Sell
53,901
-2,508
-4% -$68.2K 0.99% 33
2013
Q2 		$1.5M Buy
+56,409
New +$1.56M 1.08% 33

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Tower Trust's PFE Position: Q1 2014 in Review

Tower Trust reduced its Pfizer (PFE) stake by 8.9% in Q1 2014, selling an estimated $147K and leaving 50,487 shares worth $1.54M. The position accounts for 0.97% of the portfolio, ranked #29.

Tower Trust first reported a position in PFE in Q2 2013 and has held it in 4 quarters since. The position peaked at $1.61M in Q4 2013. 1,780 funds tracked by Wall St. Rank hold PFE as of Q1 2014.

  • Tower Trust held 50,487 shares of Pfizer worth $1.54M as of Q1 2014.
  • Tower Trust sold 4,914 Pfizer shares in Q1 2014, an estimated $147K.
  • Pfizer made up 0.97% of Tower Trust's portfolio in Q1 2014, its #29 holding.
  • Tower Trust first reported a position in Pfizer in Q2 2013 and has held it in 4 quarters since.
  • Tower Trust's Pfizer position peaked at $1.61M in Q4 2013.
  • 1,780 funds tracked by Wall St. Rank held Pfizer as of Q1 2014.

Based on Tower Trust's 13F filing for Q1 2014, filed 8 May 2014.